Staphylococcus aureus bacteremia
Showing 1 - 25 of 1,366
Staphylococcus Aureus Bacteremia, Infective Endocarditis Trial (Echocardiography evaluation)
Not yet recruiting
- Staphylococcus Aureus Bacteremia
- Infective Endocarditis
- Echocardiography evaluation
- (no location specified)
May 7, 2023
Bacteremia Due to Methicillin Susceptible Staphylococcus Aureus Trial in Paris (Cloxacillin, Cefazolin)
Recruiting
- Bacteremia Due to Methicillin Susceptible Staphylococcus Aureus
-
Paris, FranceFrançois-Xavier Lescure
Dec 7, 2022
Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Septicemia, Staphylococcal Sepsis Trial in Montreal (Ertapenem, Placebo)
Not yet recruiting
- Staphylococcus Aureus Bacteremia
- +3 more
- Ertapenem
- Placebo
-
Montreal, Quebec, CanadaMcGill University Health Centre (Royal Victoria Hospital and Mon
Feb 21, 2022
Bacteremia Due to Staphylococcus Aureus, Left Sided Infective Endocarditis (Disorder), Right Sided Infective Endocarditis
Withdrawn
- Bacteremia Due to Staphylococcus Aureus
- +3 more
- Tonabacase (LSVT-1701)
-
Butte, MontanaLsvt-1701-2001
Jun 27, 2022
Bacteremia, Staphylococcus Aureus, Staphylococcus Aureus Bacteremia Trial in United States (AP-SA02, Placebo)
Recruiting
- Bacteremia
- +4 more
- AP-SA02
- Placebo
-
Detroit, Michigan
- +3 more
May 13, 2022
Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Endocarditis Trial in Philadelphia (Oritavancin Injection)
Withdrawn
- Staphylococcus Aureus Bacteremia
- Staphylococcus Aureus Endocarditis
- Oritavancin Injection
-
Philadelphia, PennsylvaniaClinical Trials Unit. University of Pennsylvania
Mar 28, 2022
Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Septicemia, Sepsis Bacterial Trial (PET/CT)
Not yet recruiting
- Staphylococcus Aureus Bacteremia
- +6 more
- PET/CT
- (no location specified)
Apr 29, 2022
Staphylococcus Aureus Bacteremia, Anti-Bacterial Agents Trial in Seongnam-si, Seoul (N-Rephasin® SAL200, Placebo)
Terminated
- Staphylococcus Aureus Bacteremia
- Anti-Bacterial Agents
- N-Rephasin® SAL200
- Placebo
-
Seongnam-si, Gyeonggi-do, Korea, Republic of
- +1 more
Sep 12, 2021
Catheter Bacteremia, Staphylococcus Aureus Infection Trial (Dalbavancin, Standard of care)
Withdrawn
- Catheter Bacteremia
- Staphylococcus Aureus Infection
- Dalbavancin
- Standard of care
- (no location specified)
Jul 19, 2022
MRSA Bloodstream Infection, MRSA Bacteremia, MRSA Right-sided Endocarditis Trial in Butte, Toledo (Exebacase)
No longer available
- MRSA Bloodstream Infection
- +3 more
-
Butte, Montana
- +1 more
Aug 25, 2022
Staphylococcus Aureus Bacteremia Trial in Hvidovre (Antibiotic therapy duration for 7 days)
Recruiting
- Staphylococcus Aureus Bacteremia
- Antibiotic therapy duration for 7 days
-
Hvidovre, Copenhagen, DenmarkHvidovre Hospital
Oct 14, 2020
Methicillin Susceptible Staphylococcus Aureus Septicemia, Bacteremia Trial in Montreal (Daptomycin, Placebo)
Completed
- Methicillin Susceptible Staphylococcus Aureus Septicemia
- Bacteremia
- Daptomycin
- Placebo
-
Montreal, Quebec, CanadaMcGill University Health Centre (Royal Victoria Hospital, Montre
Sep 18, 2020
Staphylococcus Aureus Bacteremia Trial in Worldwide (Ceftobiprole medocaril, Daptomycin)
Completed
- Staphylococcus Aureus Bacteremia
- Ceftobiprole medocaril
- Daptomycin
-
Chula Vista, California
- +59 more
Apr 4, 2022
Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Endocarditis Trial in Worldwide (CF-301, Placebo)
Completed
- Staphylococcus Aureus Bacteremia
- Staphylococcus Aureus Endocarditis
- CF-301
- Placebo
-
Birmingham, Alabama
- +77 more
Sep 10, 2021
Staphylococcus Aureus Bacteremia Trial in Worldwide (Cefazolin, Penicillin, Clindamycin)
Recruiting
- Staphylococcus Aureus Bacteremia
- Cefazolin
- +4 more
-
Garran, Australia Capital Territory, Australia
- +73 more
Feb 23, 2022
Nasal Decolonization of Staphylococcus Aureus Trial in Uppsala (Vehicle gel, 4 + 4 applications or 4 + 2 applications, LTX-109
Completed
- Nasal Decolonization of Staphylococcus Aureus
- Vehicle gel, 4 + 4 applications or 4 + 2 applications
- +2 more
-
Uppsala, SwedenClinSmart Sweden AB
May 25, 2023
Bacteremia Trial in Columbus (Telavancin, Vancomycin, Daptomycin)
Terminated
- Bacteremia
- Telavancin
- +4 more
-
Columbus, OhioRemington-Davis Clinical Research
Feb 13, 2020
Mediastinitis and Staphylococcus Aureus
Completed
- Surgery, Cardiac
- Infection
- No intervention
-
Rennes, FranceRennes Hospital University
Dec 13, 2022
Ventilator Associated Pneumonia, Staphylococcus Aureus Trial in Limoges (Suvratoxumab, Placebo)
Recruiting
- Ventilator Associated Pneumonia
- Staphylococcus Aureus
- Suvratoxumab
- Placebo
-
Limoges, FranceResearch Site
Feb 1, 2023
Staphylococcus Aureus, Microbial Colonization, Neonatal Infection Trial in Baltimore (nasal microbiota transplant (NMT),
Not yet recruiting
- Staphylococcus Aureus
- +2 more
- nasal microbiota transplant (NMT)
- Placebo
-
Baltimore, MarylandJohns Hopkins University
Jan 12, 2023
Patients withInfections Caused by S.Aureus Like Skin Infections , Chest Infections , Surgical Site Infections , and Urinary
Not yet recruiting
- Patients withInfections Caused by S.Aureus Like Skin Infections , Chest Infections , Surgical Site Infections , and Urinary Tract Infections
- antibiotic sensitivity
-
Sohag, EgyptSohag University Hospital
Apr 13, 2023
Latent Tuberculosis, Staphylococcus Aureus Trial in Malmö (No intervention is part of the study protocol)
Recruiting
- Latent Tuberculosis
- Staphylococcus Aureus
- No intervention is part of the study protocol
-
Malmö, SwedenSkåne University Hospital
Oct 24, 2022
Infection of Total Hip Joint Prosthesis, Infection of Total Knee Joint Prosthesis Trial in Lyon (Anti-Staphylococcus aureus
Recruiting
- Infection of Total Hip Joint Prosthesis
- Infection of Total Knee Joint Prosthesis
- Anti-Staphylococcus aureus Bacteriophages
-
Lyon, FrancePr Tristan Ferry
Jun 16, 2022
Complicated Staphylococcus Aureus (S. Aureus) Infections (CSAI) Trial in Basel (FLU or CZO as continuous infusion, standard FLU
Not yet recruiting
- Complicated Staphylococcus Aureus (S. Aureus) Infections (CSAI)
- FLU or CZO as continuous infusion
- standard FLU or CZO intermittent bolus administration
-
Basel, SwitzerlandUniversity Hospital Basel, Division of Internal Medicine
Dec 14, 2022